Literature DB >> 18401811

Athletes' knowledge and views on OTC medication.

D Mottram1, N Chester, G Atkinson, D Goode.   

Abstract

A questionnaire was administered to elite athletes from Australia, Canada, the UK, and the USA representing 10 Olympic sports in order to explore knowledge and understanding of over-the-counter (OTC) medication since the removal of many of these substances from the World Anti-Doping Agency (WADA) Prohibited List, in 2004. Athletes demonstrated limited knowledge and understanding. Around half (50.5 %) knew the penalty incurred following a doping violation involving a banned OTC stimulant. The terms Monitoring Program and Specified Substance List were understood by 43.3 % and 67.5 % of respondents, respectively. Overall, the status of substances in relation to the Prohibited List was correctly identified in just 35.1 % of cases. As a whole, athletes were of the opinion that OTC stimulants posed a risk to health, were performance enhancing and that their use was against the spirit of sport. They were undecided as to whether these drugs should be returned to the Prohibited List. Elite athletes require targeted education programmes that will enable them to make informed decisions on the potential of OTC medications for therapeutic or performance enhancing purposes.

Mesh:

Substances:

Year:  2008        PMID: 18401811     DOI: 10.1055/s-2008-1038403

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  10 in total

1.  Evaluation of West-Austrian junior athletes' knowledge regarding doping in sports.

Authors:  Christina Fürhapter; Cornelia Blank; Veronika Leichtfried; Maria Mair-Raggautz; David Müller; Wolfgang Schobersberger
Journal:  Wien Klin Wochenschr       Date:  2013-01-05       Impact factor: 1.704

Review 2.  Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.

Authors:  Jaime Morente-Sánchez; Mikel Zabala
Journal:  Sports Med       Date:  2013-06       Impact factor: 11.136

3.  Health Culture and Running: Non-Elite Runners' Understandings of Doping and Supplementation.

Authors:  April D Henning
Journal:  J Amat Sport       Date:  2015

4.  The complexities of anti-doping violations: a case study of sanctioned cases in all performance levels of USA cycling.

Authors:  April D Henning; Paul Dimeo
Journal:  Perform Enhanc Health       Date:  2014 Sep-Dec

5.  National doping prevention guidelines: Intent, efficacy and lessons learned - A 4-year evaluation.

Authors:  Pia-Maria Wippert; Michael Fließer
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-10-10

6.  Self-Administration of Medicines and Dietary Supplements Among Female Amateur Runners: A Cross-Sectional Analysis.

Authors:  Médéa Locquet; Charlotte Beaudart; Robert Larbuisson; Victoria Leclercq; Fanny Buckinx; Jean-François Kaux; Jean-Yves Reginster; Olivier Bruyère
Journal:  Adv Ther       Date:  2016-10-31       Impact factor: 3.845

Review 7.  Anti-doping Policy, Therapeutic Use Exemption and Medication Use in Athletes with Asthma: A Narrative Review and Critical Appraisal of Current Regulations.

Authors:  Hayden Allen; Susan H Backhouse; James H Hull; Oliver J Price
Journal:  Sports Med       Date:  2019-05       Impact factor: 11.136

Review 8.  Energy Drinks and Sports Performance, Cardiovascular Risk, and Genetic Associations; Future Prospects.

Authors:  Jorge Gutiérrez-Hellín; David Varillas-Delgado
Journal:  Nutrients       Date:  2021-02-24       Impact factor: 5.717

9.  Relationship between Doping Prevalence and Socioeconomic Parameters: An Analysis by Sport Categories and World Areas.

Authors:  José Luís Terreros; Pedro Manonelles; Daniel López-Plaza
Journal:  Int J Environ Res Public Health       Date:  2022-07-30       Impact factor: 4.614

10.  Analysis of doping control test results in individual and team sports from 2003 to 2015.

Authors:  Millán Aguilar-Navarro; Jesús Muñoz-Guerra; María Del Mar Plara; Juan Del Coso
Journal:  J Sport Health Sci       Date:  2019-07-17       Impact factor: 7.179

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.